- Morcellators, used for fragmenting and removing large tissue masses during minimally invasive surgeries, are gaining traction in gynecological and laparoscopic procedures due to their ability to reduce surgical trauma, shorten recovery time, and enhance procedural efficiency in both hospital and outpatient settings
- The growing demand for morcellators is primarily driven by the global shift toward minimally invasive surgeries, rising incidences of uterine fibroids and other gynecological disorders, and advancements in device safety and design
- North America dominated the morcellators market with the largest revenue share of 40.5% in 2024, supported by the high volume of laparoscopic procedures, favorable reimbursement policies, and widespread adoption of advanced surgical tools, especially in the U.S. where regulatory approvals and technological innovation continue to drive growth
- Asia-Pacific is expected to be the fastest growing region in the morcellators market during the forecast period due to an expanding medical tourism sector, improving healthcare infrastructure, and rising awareness about minimally invasive procedures
- Electric Morcellator segment dominated the morcellators market with a market share of 50.5% in 2024, driven by its tissue dissection and widespread adoption in laparoscopic surgeries requiring rapid and precise tissue removal
